Two Global Leaders in Site Enablement Technology Respond to Research Site Demand for End-to-End Solutions to Increase Efficiencies Across All Trials

Florence Healthcare, the leading provider of Site Enablement Platforms for clinical trials, announced today that it has acquired VersaTrial, a cutting-edge clinical trial solutions provider.

Revolutionizing Clinical Trials: Site Enablement League Unites Industry Leaders to Accelerate Cures and Optimize Site Experience

New multiyear collaboration between Florence Healthcare and IQVIA to ensure research sites participating in IQVIA studies have access to best-in-class site enablement technology to streamline operations and power remote connectivity.

Florence, a global digital clinical research platform that connects clinical trial sponsors and study sites, launches a complementary training and certification program for clinical research and clinical operations professionals.

As there are less than two years remaining prior to the MDR enforcement, it is critical that EU device manufacturers prepare now for conformity by May 2020

In a clinical research industry that prizes speed and cost efficiency above all else, the importance of preventing EDC database delays is difficult to overstate. But how can data managers ensure they're equipped with the tools and the know-how to do so?

This webinar will offer best practices for UAT for sponsor organizations with the aim of changing the conversations and expectations around the UAT process

According to the 2017 Tufts eClinical Landscape Study, 97% of companies plan to increase use of at least one clinical data source over the next three years. But today, 98% of companies report challenges with their clinical data management systems.

Webinar describes how Agios Pharmaceuticals is solving business and data challenges by implementing a Clinical Data Hub including key selection criteria, implementation best practices, and lessons learned.

With so much at stake, where do you start when considering the right long-term strategic CRO partner? With technology and the market both priming CROs to step in as industry innovators, what attributes should sponsors look for in 'best-in-class' strategic partners?

Barbara Wuebbels, R.N., M.S., Oved Amitay, and Rod Monroy, Ph.D. set to speak at the Premier marcus evans Life Cycle of Orphan Drug Development & Commercialization Conference